IL102623A - Amide derivatives of antibiotic A40926 process for their preparation and pharmaceutical compositions containing them - Google Patents

Amide derivatives of antibiotic A40926 process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL102623A
IL102623A IL10262392A IL10262392A IL102623A IL 102623 A IL102623 A IL 102623A IL 10262392 A IL10262392 A IL 10262392A IL 10262392 A IL10262392 A IL 10262392A IL 102623 A IL102623 A IL 102623A
Authority
IL
Israel
Prior art keywords
amino
alkyl
formula
alkylamino
compound
Prior art date
Application number
IL10262392A
Other languages
English (en)
Other versions
IL102623A0 (en
Inventor
Adriano Malabara
Romeo Ciabatti
Gianbattista Panzone
Alessandra Maria Marazzi
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26128958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL102623(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of IL102623A0 publication Critical patent/IL102623A0/xx
Publication of IL102623A publication Critical patent/IL102623A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
IL10262392A 1991-07-29 1992-07-23 Amide derivatives of antibiotic A40926 process for their preparation and pharmaceutical compositions containing them IL102623A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91112685 1991-07-29
EP92109906 1992-06-12

Publications (2)

Publication Number Publication Date
IL102623A0 IL102623A0 (en) 1993-01-14
IL102623A true IL102623A (en) 1996-10-16

Family

ID=26128958

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10262392A IL102623A (en) 1991-07-29 1992-07-23 Amide derivatives of antibiotic A40926 process for their preparation and pharmaceutical compositions containing them

Country Status (24)

Country Link
EP (2) EP0596929B1 (fr)
JP (1) JP3418762B2 (fr)
KR (1) KR100242682B1 (fr)
AT (1) ATE125551T1 (fr)
AU (1) AU666862B2 (fr)
BG (1) BG61124B2 (fr)
CA (1) CA2109601C (fr)
CZ (1) CZ285703B6 (fr)
DE (1) DE69203724T2 (fr)
DK (1) DK0596929T3 (fr)
ES (1) ES2075709T3 (fr)
FI (1) FI112662B (fr)
GR (1) GR3017897T3 (fr)
HU (2) HU223946B1 (fr)
IE (1) IE68420B1 (fr)
IL (1) IL102623A (fr)
MX (1) MX9204394A (fr)
NO (1) NO314150B1 (fr)
NZ (1) NZ243735A (fr)
PL (1) PL171813B1 (fr)
RU (1) RU2125058C1 (fr)
TW (1) TW218021B (fr)
UA (1) UA41283C2 (fr)
WO (1) WO1993003060A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
AU703106B2 (en) * 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
DE69633234T2 (de) * 1995-07-05 2005-09-15 Aventis Bulk S.P.A. Reinigung von dalbeheptide-antibiotika mittels isoelektrofokussierung
KR20000010589A (ko) * 1996-04-23 2000-02-15 클라우디오 쿼르타 항생제a40926의아미드유도체의개선된화학적제조방법
US6004959A (en) * 1996-05-30 1999-12-21 Hoechst Marion Roussel, Inc. Alkyloxyamino substituted fluorenones and their use as protein kinase-C inhibitors
SG87877A1 (en) * 1998-12-23 2002-04-16 Advanced Medicine Inc Glycopeptide derivatives and pharmaceutical compositions containing the same
US6392012B1 (en) 1998-12-23 2002-05-21 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
KR100478533B1 (ko) * 2002-07-30 2005-03-28 한국수력원자력 주식회사 레이저를 이용한 탈륨 동위원소 분리방법
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003294262B2 (en) 2002-11-18 2007-08-23 Vicuron Pharmaceuticals Inc. Methods of administering dalbavancin for treatment of bacterial infections
US20060074014A1 (en) 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
US7521418B2 (en) 2003-05-27 2009-04-21 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
DE602004010915T2 (de) 2003-07-22 2008-12-11 Theravance, Inc., South San Francisco Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel
JP4330169B2 (ja) 2004-11-29 2009-09-16 国立大学法人名古屋大学 グリコペプチド抗生物質モノマー誘導体
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
KR20100109934A (ko) 2007-12-26 2010-10-11 시오노기세야쿠 가부시키가이샤 글리코펩티드 항생 물질 배당화 유도체
US20240083950A1 (en) * 2021-01-11 2024-03-14 Xellia Pharmaceuticals Aps Synthesis process

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608809D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Antibiotic
GB8726859D0 (en) * 1987-11-17 1987-12-23 Lepetit Spa 22-dechlorotei-coplanins
ATE134646T1 (de) * 1988-12-27 1996-03-15 Lepetit Spa C63-amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplanine
GB2231846B (en) * 1989-05-25 1993-02-24 Hadlum Brothers Ltd A hand held carrier
WO1992010516A1 (fr) * 1990-12-05 1992-06-25 Gruppo Lepetit S.P.A. Derives 38-decarboxy-38-hydroxymethyles d'antibiotiques a teicoplanine, et procede de preparation
EP0505735A1 (fr) * 1991-03-27 1992-09-30 GRUPPO LEPETIT S.p.A. Dérivés d'esters de l'antibiotique A 40926

Also Published As

Publication number Publication date
TW218021B (fr) 1993-12-21
GR3017897T3 (en) 1996-01-31
HU211347A9 (en) 1995-11-28
KR100242682B1 (ko) 2000-02-01
FI940394L (fi) 1994-01-26
BG61124B2 (bg) 1996-11-29
NO314150B1 (no) 2003-02-03
EP0596929B1 (fr) 1995-07-26
WO1993003060A1 (fr) 1993-02-18
DE69203724D1 (de) 1995-08-31
IL102623A0 (en) 1993-01-14
EP0525499A1 (fr) 1993-02-03
DK0596929T3 (da) 1995-09-11
HU9400256D0 (en) 1994-05-30
CZ19294A3 (en) 1994-11-16
HU223946B1 (hu) 2005-03-29
ATE125551T1 (de) 1995-08-15
RU2125058C1 (ru) 1999-01-20
CZ285703B6 (cs) 1999-10-13
MX9204394A (es) 1993-01-29
IE68420B1 (en) 1996-06-12
CA2109601A1 (fr) 1993-02-18
DE69203724T2 (de) 1996-01-18
CA2109601C (fr) 2002-07-02
IE922451A1 (en) 1993-02-10
AU2326292A (en) 1993-03-02
HUT66080A (en) 1994-09-28
UA41283C2 (uk) 2001-09-17
FI940394A0 (fi) 1994-01-26
JP3418762B2 (ja) 2003-06-23
NO934722D0 (no) 1993-12-20
EP0596929A1 (fr) 1994-05-18
ES2075709T3 (es) 1995-10-01
AU666862B2 (en) 1996-02-29
JPH06509347A (ja) 1994-10-20
NO934722L (no) 1994-02-14
PL171813B1 (pl) 1997-06-30
NZ243735A (en) 1995-01-27
FI112662B (fi) 2003-12-31

Similar Documents

Publication Publication Date Title
US5750509A (en) Amide derivatives of antibiotic A 40926
EP0596929B1 (fr) Derives amides de l'antibiotique a 40926
EP0465481B1 (fr) Nouveaux derives d'alkylamides substitues de teicoplanine
EP0376041B1 (fr) Dérivés amides en C63 des 34-de(acétylglucosaminyl)-34-déoxyteicoplanines
EP0316712A2 (fr) 22-Déchlorotéicoplanines
EP0698041B1 (fr) Antibiotiques a base d'aglucodalbaheptides synthetiques
US5438117A (en) Hexapeptides deriving from aglucoteicoplanin and a process for preparing them
AU647122B2 (en) C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy- teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
US4789661A (en) De-(acetylglucosaminyl)-di(dehydro)-deoxy teicoplanin derivatives
EP0560795B1 (fr) Derives 38-decarboxy-38-hydroxymethyles d'antibiotiques a teicoplanine, et procede de preparation
EP0563062B1 (fr) Hexapeptides derives de l'aglucoteicoplanine, et procede de preparation
US5164484A (en) De-(acetylglucosaminyl-di(dehydro)-deoxy teicoplanin derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees